Literature DB >> 3709617

Reduced bioavailability and effect of furosemide given with food.

B Beermann, C Midskov.   

Abstract

10 healthy volunteers were given 40 mg furosemide p.o. with and without breakfast. The meal reduced the peak level of furosemide and decreased its bioavailability by approximately 30%. A heavy meal given to 5 of the subjects had no further effect. The reduced bioavailability caused a reduction in the diuretic effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709617     DOI: 10.1007/bf00615967

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Gas chromatographic determination of furosemide in plasma using an extractive alkylation technique and an electron capture detector.

Authors:  B Lindström; M Molander
Journal:  J Chromatogr       Date:  1974-12-04

2.  Pharmacokinetics of orally administered furosemide.

Authors:  M R Kelly; R E Cutler; A W Forrey; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

3.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.

Authors:  M M Hammarlund; L K Paalzow; B Odlind
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Kinetics and dynamics of furosemide and slow-acting furosemide.

Authors:  B Beermann
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

  4 in total
  12 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

4.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 5.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 6.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 7.  Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome.

Authors:  Zachary L Cox; Veena S Rao; Jeffrey M Testani
Journal:  Kidney360       Date:  2022-03-01

8.  Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure.

Authors:  David Pham; Justin L Grodin
Journal:  Card Fail Rev       Date:  2017-11

Review 9.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

10.  Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.

Authors:  Edward Chong; Veena Kalia; Sandra Willsie; Peter Winkle
Journal:  J Nephrol       Date:  2014-04-04       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.